Home Page
News Lines
Classifieds
Real Estate
Press Releases
Arcade
Business Directory
Automotive
Towns
Long Island New York
Google Web Site
 
 

BIOTECHNOLOGY NEWS LINES

Advertisement



Discovery of Gene May Lead to New Male Contraceptive THURSDAY, May 24 (HealthDay News) -- The discovery of a key gene involved in sperm development could eventually lead to the creation of a new type of non-hormonal birth control for men, a study involving mice suggests.




New CEO takes the helm at biotech giant Amgen Biotech drugmaker Amgen Inc. introduced new CEO Bob Bradway to shareholders Wednesday at the company's annual meeting, with retiring CEO Kevin Sharer stepping down after a decade running the world's largest biotech company.


Scientists deploy genetics in search for bigfoot LONDON (Reuters) - Scientists are turning to genetic testing to see if they can prove the existence of the elusive hairy humanoid known across the world as bigfoot, yeti and sasquatch. A joint project between Oxford University and Switzerland's Lausanne Museum of Zoology will examine organic remains that some say belong to the creature that has bee......


Gene Tests May Not Drive Patients to More Medical Care FRIDAY, May 18 (HealthDay News) -- Personal genetic testing does not lead to an increased use of health services, a new study finds.


Osiris shares climb on stem-cell therapy approval Shares of Osiris Therapeutics traded higher Friday, a day after Canadian regulators approved the company's first-of-a-kind stem cell therapy Prochymal, a treatment for a deadly side effect of bone marrow transplants.


Canada OKs Osiris drug; first stem cell therapy BOSTON (Reuters) - Osiris Therapeutics Inc said on Thursday that Canadian health regulators have approved its treatment for acute graft-versus host disease in children, making it the first stem cell drug to be approved for a systemic disease anywhere in the world. Osiris shares rose 14 percent to $6.00 in extended trading after the news was announc......


Canada OKs Osiris drug; first stem cell therapy BOSTON (Reuters) - Osiris Therapeutics Inc said on Thursday that Canadian health regulators have approved its treatment for acute graft-versus host disease in children, making it the first stem cell drug to be approved for a systemic disease anywhere in the world. Osiris shares rose 14 percent to $6.00 in extended trading after the news was announc......


Osiris stem cell therapy approved in Canada Osiris Therapeutics Inc. said Thursday that Canadian regulators approved its stem cell therapy Prochymal, which is intended to treat a deadly side effect of bone marrow transplants.


Study unpicks gene changes behind breast cancer

A woman undergoes a free mammogram inside Peru's first mobile unit for breast cancer detection, in LimaLONDON (Reuters) - Scientists have mapped the complete genetic codes of 21 breast cancers and created a catalogue of the mutations that accumulate in breast cells, raising hopes that the disease may be able to be spotted earlier and treated more effectively in future. The research, the first of its kind, untangles the genetic history of how cancer ......




B.C.'s organic growers browned off by bid to wipe browning gene from apples KELOWNA, B.C. - Orchardists in B.C.'s Okanagan region worry that the introduction of genetically modified trees could take a bite out of fruit sales.


You can save this news page by submitting it to your favorite sites: Social Bookmark News

All News Lines - Local and World Wide, Updated Hourly

RSS news lines are HTML instructions and not actual copy. They are displayed here through the doctrine of fair use in the U.S. Copyright Act which allows us to show snippets and links to news and other materials. The fair use doctrine protects limited uses of content, such as indexing to make it easier to find. This allows us to send visitors to breaking news web sites. If your news appears here against your wishes please contact us for removal, disable your RSS feeds or implement simple technical standards such as robots.txt or metatags to prevent search engines (Yahoo and MSN) from feeding us your snippets and links.

 

 
   By using this site you agree to our Terms of Service and Privacy Policy. If you do not agree, please exit the service.
   Copyright © 2002 - 2012 Long Island Exchange ® Inc. All rights reserved. Internet Marketing by Searchen Networks ® Inc.